Lee J H, Lee C T, Yoo C G, Hong Y K, Kim C M, Han S K, Shim Y S, Carbone D P, Kim Y W
Department of Internal Medicine, Seoul National University College of Medicine, Korea.
Anticancer Res. 1998 Sep-Oct;18(5A):3257-61.
Abnormalities in the p16INK4a tumor suppressor gene are found in many lung cancer cell lines and primary lung cancer tissue. To examine its tumor suppressor function and potential adequacy in cancer gene replacement therapy, wild-type p16INK4a gene was inserted in an adenovirus derived gene delivery system and introduced into lung cancer cell lines (NCI-H441 and NCI-H157) that did not express p16INK4a. Western blot assay and immunocytochemistry demonstrated production of wild-type p16 protein in these cell lines. The biological function of exogenous p16 protein was confirmed by the inhibition of pRB phosphorylation. The expression of exogenous p16 protein via recombinant adenovirus significantly inhibited cancer cell growth and colony formation in vitro of NSCLC that can not express endogenous p16. The flow cytometric analysis showed these results correlated with G1 cell cycle arrest. These observations suggest the value of adenovirally-mediated p16INK4a gene replacement therapy for lung cancer.
在许多肺癌细胞系和原发性肺癌组织中均发现了p16INK4a肿瘤抑制基因的异常。为了检测其肿瘤抑制功能以及在癌症基因替代疗法中的潜在适用性,将野生型p16INK4a基因插入腺病毒衍生的基因递送系统中,并导入不表达p16INK4a的肺癌细胞系(NCI-H441和NCI-H157)。蛋白质免疫印迹分析和免疫细胞化学显示这些细胞系中产生了野生型p16蛋白。通过抑制pRB磷酸化证实了外源性p16蛋白的生物学功能。通过重组腺病毒表达的外源性p16蛋白显著抑制了非小细胞肺癌(NSCLC)体外癌细胞的生长和集落形成,这些NSCLC无法表达内源性p16。流式细胞术分析表明这些结果与G1期细胞周期停滞相关。这些观察结果提示腺病毒介导的p16INK4a基因替代疗法对肺癌的价值。